These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12767509)
1. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Sikdar N; Mahmud SA; Paul RR; Roy B Cancer Lett; 2003 May; 195(1):33-42. PubMed ID: 12767509 [TBL] [Abstract][Full Text] [Related]
2. Role of CYP2E1 genetic polymorphism in the development of oral leukoplakia among tobacco users in North Indian population. Gupta S; Gupta OP; Srivastava S Indian J Cancer; 2014; 51(2):154-8. PubMed ID: 25104199 [TBL] [Abstract][Full Text] [Related]
3. Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Sam SS; Thomas V; Reddy KS; Surianarayanan G; Chandrasekaran A J Cancer Res Clin Oncol; 2010 Jun; 136(6):945-51. PubMed ID: 20012094 [TBL] [Abstract][Full Text] [Related]
4. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk. Cury NM; Russo A; Galbiatti AL; Ruiz MT; Raposo LS; Maniglia JV; Pavarino EC; Goloni-Bertollo EM Mol Biol Rep; 2012 Feb; 39(2):1055-63. PubMed ID: 21590276 [TBL] [Abstract][Full Text] [Related]
6. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060 [TBL] [Abstract][Full Text] [Related]
8. A case-control study of CYP2E1 (PstI) and CYP1A1 (MspI) polymorphisms in colorectal cancer. Proença MA; Fernandes GM; Russo A; Lelis RB; Netinho JG; Cunrath GS; Silva AE; Goloni-Bertollo EM; Pavarino EC Genet Mol Res; 2015 Dec; 14(4):17856-63. PubMed ID: 26782431 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Majumder M; Sikdar N; Paul RR; Roy B Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2106-12. PubMed ID: 16172217 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China. Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659 [TBL] [Abstract][Full Text] [Related]
11. Interactions between cigarette smoking and polymorphisms of xenobiotic-metabolizing genes: the risk of oral leukoplakia. Li YF; Sung FC; Tsai MH; Hua CH; Liu CS; Huang YT; Yeh CC Dis Markers; 2013; 34(4):247-55. PubMed ID: 23396292 [TBL] [Abstract][Full Text] [Related]
12. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018 [TBL] [Abstract][Full Text] [Related]
13. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720 [TBL] [Abstract][Full Text] [Related]
14. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease]. Wang J; Liu Z; Chen B Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822 [TBL] [Abstract][Full Text] [Related]
15. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis. Yaming P; Urs AB; Saxena A; Zuberi M Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973 [TBL] [Abstract][Full Text] [Related]
17. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population. Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184 [TBL] [Abstract][Full Text] [Related]
18. CYP2E1 genetic polymorphism with dietary, tobacco, alcohol habits, H. pylori infection status and susceptibility to stomach cancer in Mizoram, India. Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Baruah D; Mahanta J; Narain K Asian Pac J Cancer Prev; 2014; 15(20):8815-22. PubMed ID: 25374213 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. Datta S; Majumder M; Biswas NK; Sikdar N; Roy B Cancer; 2007 Nov; 110(9):1991-9. PubMed ID: 17886251 [TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Sikdar N; Paul RR; Roy B Int J Cancer; 2004 Mar; 109(1):95-101. PubMed ID: 14735473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]